Calliditas Therapeutics AB (publ)
CLTEF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $0 | $0 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | $1 |
| % Margin | -14,236.9% | – | – | 90.5% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -258,779.1% | – | – | -5.4% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -273,630.5% | – | – | -8.5% |
| EPS Diluted | -0.006 | 0 | -0.004 | -0.88 |
| % Growth | – | 100% | 99.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |